.jpeg)
New Delhi, January 17, 2025: OPTM Healthcare has today unveiled its flagship clinic at South Extension, New Delhi , marking the beginnin...
New Delhi, January 17, 2025: OPTM Healthcare has today unveiled its flagship clinic at South Extension, New Delhi, marking the beginning of the brand’s groundbreaking efforts to pioneer muscle-centric natural pain care. The launch event successfully demonstrated OPTM Healthcare’s renewed mission to bring forth practitioner-and-tech-led solutions for enabling pain-free living and optimizing one’s muscle health. The brand, which was earlier focused on comprehensive pain management for nearly all types of musculoskeletal disorders, has now pivoted strategically and has narrowed down its focus to only address knee osteoarthritis and spine degenerative disorders.
OPTM’s new clinic
in New Delhi – exemplifying its steadfast commitment to helping patients become
pain-free by reversing their muscle age – is spread over a vast 3500 sq. ft
area. Equipped and integrated with cutting-edge tools and technologies and
in-house diagnostic labs, the clinic boasts of a superlative range of services
and spaces designed to carry out optimal diagnosis, pain management and
transformative care.
Notably, at the
heart of the clinic’s offerings is OPTM’s ‘Bio-Musculo Index’ – a diagnostic
innovation backed by several years of clinical research, and developed and
marketed by Varco Leg Care – India’s leading consumer healthtech brand
dedicated to leg care, which was also demonstrated today. This AI-enabled precision
testing device powered by Varco, a first-of-its-kind in the entire world, grades
muscle health analysing 10 different biomarkers, and thereafter using a
proprietary AI algorithm, determines one’s muscle age and unlocks unparalleled
insights for creating personalized treatment plans. Thereafter, OPTM’s
effective phyto-topical formulations’-based muscle-centric treatment protocol
is being initiated, which entails a phydigital approach incorporating measurable
and trackable progress milestones through
a revolutionary motion sensing
technology. The non-toxic, side-effects-free treatment process operates at
the cellular level to reverse degeneration, eventually eliminating the
recurring cycle of pain and reversing muscle age, thereby potentially
eliminating the requirement for joint surgeries in many cases (especially for
patients between stage 1 and stage 3).
Dr. Raghav Sehgal,
PhD from Yale University, Director at Healthy Longevity Clinic USA & and
Principal, Longevity Tech Fund, and Dr. Michael Lim, Founder
& CEO, Cell Genesis (Singapore-based), who were present as chief
guests, inaugurated the clinic. The attendees at this launch event were also introduced
to OPTM’s signature, patent-pending evidence-based phytotherapy –
a plant-based, 100% natural, non-invasive treatment methodology that has been
clinically proven to reverse muscle aging by promoting cellular-level repair
and restoration. In addition to OPTM’s flagship phytotherapy module, the clinic
also features FDA-approved devices for implementing cryotherapy
and lymphatic compression therapy, thus embracing a comprehensive
approach to patient care. At the event, OPTM also announced its ambitious expansion
plans to introduce 10 new clinics in the next 9 months, while also
parallelly growing its team of domain experts, including certified physiotherapists, health coaches, Ayurvedic doctors and Orthopaedic
surgeons.
Dr. Raghav Sehgal spoke at length
about translating longevity science to clinical outcomes. On the other hand,
Dr. Lim emphasized upon the pivotal role of improving muscle health in
terms of extending human healthspan.
Suresh Jain, Anchor
Investor, Sunicon Ventures and Managing Director at The Alan Scott Initiative, lauded OPTM
Healthcare’s dedication towards delivering sustainable results and lasting
impact by leveraging scientific aptitude and expertise, and spoke at length
about how The Alan Scott Initiative is driving trailblazing innovations in the
healthcare space with technology integration. “I am proud to support OPTM, an Alan Scott Initiative startup that
is fostering innovations across the exciting domains of regenerative medicine,
AI-enabled diagnosis, and phyto-therapeutics,” Suresh Jain added.
Notably, Dr.
Apurba Ganguly, Founder, Chairman & Chief Scientist Officer of OPTM
Healthcare is a veteran researcher, scientist and inventor. With his
research spanning over three-and-a-half decades, he has established and
verified the fact that the root cause of joint degeneration and pain lies in
muscle weakness and muscle ageing – a revelation that paved the way for OPTM to
embrace the revolutionary approach of root cause-oriented healing for
sustainable results, as compared to traditional symptoms’-based pain relief
processes followed till date by medical practitioners worldwide.
Speaking at the
launch event, Dr. Apurba Ganguly said, “Since inception, our goal at
OPTM Healthcare has been to empower individuals to reclaim their mobility and
thrive. And by addressing the root causes of pain and degeneration, we are now
are at the cusp of redefining what it means to live a healthy, active life, as
we go beyond managing symptoms to tackling pain at its source. With the launch
of our latest state-of-the-art clinic in the national capital, we are taking a
pivotal step embarking on a journey to achieving an unmatchable track-record of
treating patients with knee and spine degenerative disorders such as and lumbar
spine and cervical issues. The new clinic embodies our vision and capabilities
to usher a revolution and unprecedented transformation in pain management. Our
disruptive approach heralds a future where natural, sustainable solutions can
potentially either complement or at times replace invasive surgeries, restoring
vitality, mobility, and longevity like never before.”
By integrating
research-backed innovations with focussed interventions towards holistic pain care,
OPTM aims to set a new benchmark in the healthcare industry, while working
hand-in-hand with the medical practitioners’ ecosystem. Their new clinic
represents a distinctive and future-ready platform heralding the brand’s
journey to optimize pain management and muscle health, while aligning with its long-term
vision of unlocking a longer, pain-free life for patients. The event concluded
with an engaging demonstration of OPTM’s AI-powered biomarker test and a guided
tour of the cutting-edge facility, leaving attendees inspired with the brand’s pathbreaking
vision for revolutionizing the future of musculoskeletal healthcare and muscle-centric
treatment.
About OPTM
Healthcare
Imagine a world
where pain is not just treated but understood, where AI and blood biomarkers
redefine diagnosis and treatment of pain, giving patients solutions tailored to
their unique needs. This is the future of healthcare, reimagined by us at OPTM.
We believe that
healthy living isn’t just about managing pain – it’s about restoring effortless
body movement, vitality, and freedom to live fully. Through advanced
diagnostics, targeted therapies, and continuous care at our clinics, OPTM is
empowering individuals to reclaim their mobility and thrive. With innovations across
regenerative medicine, emerging-tech, and phyto-therapies, we are paving the
way for a future where pain is no longer a barrier but a bridge to better
health. We are certified by the Ministry of Ayush, Government of India and the
European Medical Association and have presence across 3 Indian cities as of
date.
Website: https://www.optmhealthcare.in
No comments